Conservative Treatment Versus Operative Plate Fixation for Acute, Displaced Fractures of the Distal Clavicle
A Multicentre, Randomized Trial of Conservative Treatment Versus Operative Plate Fixation for Acute, Displaced Fractures of the Distal Clavicle
1 other identifier
interventional
59
1 country
1
Brief Summary
This is a multicentre randomized clinical trial prospectively comparing operative treatment versus conservative (nonoperative) care in the management of displaced distal (Type II) clavicle fractures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2009
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedFirst Submitted
Initial submission to the registry
March 30, 2009
CompletedFirst Posted
Study publicly available on registry
March 31, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2019
CompletedNovember 27, 2019
November 1, 2019
9.8 years
March 30, 2009
November 25, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome measurement will be patient DASH (Disabilities of the Arm, Shoulder and Hand Instrument) scores. The DASH is a patient-oriented, limb-specific, functional measurement questionnaire.
2 years
Secondary Outcomes (1)
The secondary outcome measurement patients' functional shoulder scores as defined by Constant's Shoulder Score (i.e. pain, activities of daily living, range of motion and power).
2 years
Study Arms (2)
Non-operative treatment
OTHERThe first treatment strategy will involve conservative (nonoperative) management of the clavicle fracture.
Operative treatment
ACTIVE COMPARATORThe second treatment strategy will involve operative fixation (i.e. ORIF) of the fracture with a plate and screws.
Interventions
Standard protocol for conservative treatment will consist of the implementation of a sling, for clavicular support and patient comfort. Pendulum or gentle Range of Motion (ROM) shoulder exercises may be implemented at any time as dictated by the attending surgeon.
The operating surgeon will determine the positioning of the patient for surgery. ORIF of the distal clavicle fracture will be carried out as follows: Anatomic reduction of the fracture Definitive fixation with a contoured clavicle plate and screws; a AO hook plate; a 3.5 LCDC, reconstruction, or compression plate is acceptable; a 1/3 tubular plate is not acceptable Use of bone graft is optional (iliac crest bone autograft)
Eligibility Criteria
You may qualify if:
- Men or women aged 16 to 60 years of age
- Completely displaced (no cortical contact), closed fracture of the distal 3rd of the clavicle (Type II) confirmed by radiograph
- Fractures within 28 days post injury
- Provision of informed consent
You may not qualify if:
- Pathological fractures
- Non-displaced (cortical contact) distal clavicle fractures
- Open clavicle fractures
- Presence of vascular injury
- Fractures more than 28 days post-injury
- Limited life expectancy due to significant medical co-morbidity
- Medical contraindication to surgery
- Inability to comply with rehabilitation or form completion
- Likely problems, in the judgement of the investigators, with maintaining follow-up (i.e. patients with no fixed address, patients not mentally competent to give consent, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Unity Health Torontolead
- Fraser Healthcollaborator
- University of British Columbiacollaborator
- London Health Sciences Centrecollaborator
- University of Calgarycollaborator
- Nova Scotia Health Authoritycollaborator
- Winnipeg Regional Health Authoritycollaborator
- McGill University Health Centre/Research Institute of the McGill University Health Centrecollaborator
- The Ottawa Hospitalcollaborator
Study Sites (1)
St. Michael's Hospital
Toronto, Ontario, M5C 1R6, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeremy A Hall, MD, FRCS(C)
Unity Health Toronto
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 30, 2009
First Posted
March 31, 2009
Study Start
March 1, 2009
Primary Completion
December 1, 2018
Study Completion
September 1, 2019
Last Updated
November 27, 2019
Record last verified: 2019-11